BioNexus Gene Lab Corp (BGLC)
BGLC trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.32
-5.01% on the day
Market cap
$3.9M
Nano cap
Revenue · 2025
$7.4M
-21.9% on 2024
Net income · 2025
-$3.0M
-40.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BGLC on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | Malaysia |
| IPO year | Not reported by the screener |
| SEC CIK | 0001737523 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | WY |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $7.4M |
| Net income | -$3.0M |
| Operating income | -$3.0M |
| Net margin | -40.2% |
| Operating margin | -39.9% |
| Revenue growth | -21.9% |
| Cash | $2.4M |
| Total assets | $9.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2025-11-07 |
| Latest annual report FORM 10-K | 10-K | 2026-04-14 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-10-07 |
| Latest proxy | DEF 14A | 2025-12-03 |
Source: SEC EDGAR submissions feed, 156 recent filings. All filings on EDGAR.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ACON | Aclarion Inc. | $2.14 | -4.68% | $6.2M |
| AMS | American Shared Hospital Services | $1.27 | 0.00% | $8.4M |
| ADVB | Advanced Biomed Inc. | $5.16 | -2.18% | $8.5M |
| ACH | Accendra Health Inc. | $0.3151 | -19.31% | $24.2M |
| MDXH | MDxHealth SA | $0.6600 | +9.29% | $63.0M |
| SERA | Sera Prognostics Inc. | $2.04 | -1.45% | $80.5M |
| KEQU | Kewaunee Scientific Corporation | $32.20 | -0.62% | $93.2M |
| BNR | Burning Rock Biotech Limited | $15.00 | 0.00% | $158.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier